Madej-Pilarczyk A, Kochański A
Dr Agnieszka Madej-Pilarczyk, Neuromuscular Unit, Mossakowski Medical Research Centre, Polish Academy of Sciences, 5 Pawińskiego St., 02-106 Warsaw, Poland, phone: +48 22 608 66 01, fax: +48 22 608 65 31, e-mail:
Folia Neuropathol. 2016;54(1):1-8. doi: 10.5114/fn.2016.58910.
Emery-Dreifuss muscular dystrophy (EDMD), a rare inherited disease, is characterized clinically by humero-peroneal muscle atrophy and weakness, multijoint contractures, spine rigidity and cardiac insufficiency with conduction defects. There are at least six types of EDMD known so far, of which five have been associated with mutations in genes encoding nuclear proteins. The majority of the EDMD cases described so far are of the emerinopathy (EDMD1) kind, with a recessive X-linked mode of inheritance, or else laminopathy (EDMD2), with an autosomal dominant mode of inheritance. In the work described here, the authors have sought to describe the history by which EDMD came to be distinguished as a separate entity, as well as the clinical and genetic characteristics of the disease, the pathophysiology of lamin-related muscular diseases and, finally, therapeutic issues, prevention and ethical aspects.
埃默里-德赖富斯肌营养不良症(EDMD)是一种罕见的遗传性疾病,其临床特征为肱腓肌萎缩和无力、多关节挛缩、脊柱僵硬以及伴有传导缺陷的心脏功能不全。迄今为止已知的EDMD至少有六种类型,其中五种与编码核蛋白的基因突变有关。到目前为止所描述的大多数EDMD病例属于埃默菌素病(EDMD1)类型,具有隐性X连锁遗传模式,或者属于核纤层蛋白病(EDMD2),具有常染色体显性遗传模式。在本文所述的研究中,作者试图描述EDMD被区分为一个独立疾病实体的历程,以及该疾病的临床和遗传特征、核纤层蛋白相关肌肉疾病的病理生理学,最后还有治疗问题、预防和伦理方面。